Diabetes that starts after a pancreas attack in African American and Hispanic adults
Mechanisms of diabetes from acute pancreatitis in African Americans and Hispanics
This project follows Black and Hispanic adults who had acute pancreatitis to learn how and why some go on to develop diabetes afterward.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11232910 on NIH RePORTER |
What this research studies
If you had acute pancreatitis, researchers at the University of Illinois Chicago will invite you to join a long-term group called DREAM where they collect health information, blood and stool samples, and diet details over time. The team includes doctors and scientists from UIC and Northwestern and will combine clinical follow-up with tests of the gut microbiome, metabolism, and other biological markers. They will use modern AI tools to look for patterns that predict who develops diabetes and which factors (like diet or microbes) might play a role. Results will be shared across the consortium to help shape better prevention and monitoring for people like you.
Who could benefit from this research
Good fit: Adults who recently experienced acute pancreatitis, particularly African American or Hispanic individuals, who can attend clinic visits and provide health information and biospecimens are ideal candidates.
Not a fit: People without a history of acute pancreatitis, children, or anyone unable or unwilling to attend follow-up visits or provide samples are unlikely to benefit from participating.
Why it matters
Potential benefit: If successful, this work could help doctors predict who is at higher risk of diabetes after pancreatitis and guide earlier prevention or monitoring, especially for Black and Hispanic patients.
How similar studies have performed: Previous observational studies have linked pancreatitis to later diabetes but the detailed biological mechanisms remain unclear, and combining multi-omics with AI is a newer approach in this area.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Yazici, Cemal — University of Illinois at Chicago
- Study coordinator: Yazici, Cemal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.